Big Pharma Split Corp Class A (PRM) — Net Asset Quality Index
Big Pharma Split Corp Class A (PRM) has a Net Asset Quality Index of 57.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$31.84 Million minus total liabilities of CA$13.57 Million yields net assets of CA$18.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Big Pharma Split Corp Class A debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Big Pharma Split Corp Class A Net Asset Quality Index Over Time (2017–2025)
This chart shows how Big Pharma Split Corp Class A's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 57.4%, representing net assets of CA$18.27 Million against total assets of CA$31.84 Million CAD. For live market cap and overall valuation, see how much is Big Pharma Split Corp Class A worth.
Annual Net Asset Quality Index for Big Pharma Split Corp Class A (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Big Pharma Split Corp Class A from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Big Pharma Split Corp Class A (PRM) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 57.4% | CA$18.27 Million | CA$31.84 Million | CA$13.57 Million | ▲ +5.4 pp |
| 2024 | 52.0% | CA$13.68 Million | CA$26.30 Million | CA$12.62 Million | ▼ -7.7 pp |
| 2023 | 59.7% | CA$15.85 Million | CA$26.53 Million | CA$10.68 Million | ▲ +9.3 pp |
| 2022 | 50.5% | CA$19.73 Million | CA$39.10 Million | CA$19.37 Million | ▼ -8.8 pp |
| 2021 | 59.2% | CA$22.40 Million | CA$37.81 Million | CA$15.41 Million | ▲ +1.8 pp |
| 2020 | 57.5% | CA$13.19 Million | CA$22.93 Million | CA$9.75 Million | ▼ -2.5 pp |
| 2019 | 60.0% | CA$16.31 Million | CA$27.18 Million | CA$10.87 Million | ▲ +4.0 pp |
| 2018 | 56.0% | CA$18.84 Million | CA$33.63 Million | CA$14.79 Million | ▼ -1.5 pp |
| 2017 | 57.5% | CA$18.68 Million | CA$32.49 Million | CA$13.81 Million | — |